Abstract
Introduction: PQA-18 (prenylquinoline carboxy derivative 18) is a novel immunosuppressant that inhibits PAK-2 and suppresses cytokine production and macrophage (Mφ) differentiation/proliferation. The effect of PQA-18 was evaluated using a rat small intestine transplant model. Methods: Male Dark Agouti (DA) (RT-1a) and Lewis (RT-1l) rats, 7 to 9 weeks old, were used as donors and recipients, respectively. An approximately 15 cm ileal grafts from the donor was heterotopically transplanted to the recipient rats. Recipients were administered PQA-18 (4 mg/kg/day) intraperitoneal injection from post-operative day1 (POD1) for two weeks. (1) The survival time of the graft was compared between the non-administration group (ITx-g) and the PQA administered group (PQA-g). The rejection was manifested by progressive stoma ischemia, necrosis and the development of an abdominal mass, based on our previous studies. (2) At POD6, CD3 + T cells were separated from recipient mesenteric lymph nodes and mixed lymphocyte reaction (MLR) was performed. (3) Further, the % of Mφ in the graft mesenteric lymph node (gMLN) and graft Peyer’s patch (gPP) was measured by FACS. (4) Bone marrow stem cells of Lewis rat were cultured with G-CSF for 4 days, with or without PQA-18, and the differentiation/proliferation of Mφ was also measured by FACS. Results: (1) The graft survival time was prolonged from 7.0 ± 0.77 days in ITx-g (n = 9) to 10.7 ± 1.26 days in PQA-g (n = 10) (p <0.001). However, there was no difference between the two groups in serum creatinine and BUN on POD10 and POD14, measured for the evaluation of renal function. (2) MLR showed a suppression of T cell proliferation in PQA-g compared with ITx-g: 9.44 ± 1.21 vs 4.71 ± 0.55 (n = 4) (p <0.05), respectively. (3) The % of Mφ in the graft was 60.55 ± 2.18% (ITx-g) vs 45.20 ± 3.20% (PQA-g)(n = 6) (p <0.01) for gMLN and 42.42 ± 3.61% (ITx-g) vs 29.8% ± 3.21% (PQA-g) (n = 6) for gPP (p <0.05). In addition, the decreation of Mφ was observed in all cases of PQA-g. (4) The % of Mφ differentiation was reduced in the dose dependent manner. The group with 20μM of PQA-18 showed 5.01 ± 2.09% (n = 6), vs 14.45 ± 2.40% (control) (p <0.05). Conclusion: PQA-18 significantly prolonged the survival of rat small intestinal grafts by suppressing the Mφ infiltration in the grafts and lymph nodes. JSPS KAKENHI Grant Number JP17K17001.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.